辰欣药业上涨7.75%，报33.94元/股

Core Viewpoint - The stock price of Chenxin Pharmaceutical increased by 7.75% on August 15, reaching 33.94 CNY per share, with a trading volume of 448 million CNY and a turnover rate of 3.05%, resulting in a total market capitalization of 15.366 billion CNY [1] Company Overview - Chenxin Pharmaceutical Co., Ltd. is located in Jining High-tech Zone, Tongji Technology Industrial Park, and is a comprehensive pharmaceutical enterprise engaged in research and development, production, and sales [1] - The company focuses on independently developing and producing drugs that fill domestic gaps, investing 6% of its annual sales revenue into scientific research [1] - Successful drug developments include Adefovir Dipivoxil, and the company has established long-term cooperative relationships with several research institutions [1] Financial Performance - For the period from January to March 2025, Chenxin Pharmaceutical reported operating revenue of 920 million CNY, a year-on-year decrease of 19.91% [1] - The net profit attributable to shareholders was 144 million CNY, reflecting a year-on-year decrease of 11.86% [1] - As of March 31, the number of shareholders was 21,400, with an average of 21,200 circulating shares per person [1]